---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-22-005479"
form_type: "8-K"
ticker: "GTHP"
cik: "0000924515"
company_name: "GUIDED THERAPEUTICS INC"
filed_at: "2022-07-29T23:59:59+00:00"
generated_at: "2026-06-24T07:11:21.279202+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Guided Therapeutics cancels previously approved 1-for-20 reverse stock split, renders amendment void

## Summary
- Certificate of Correction filed July 25, 2022, nullifies December 30, 2021 reverse split amendment ab initio.
- FINRA never declared the reverse split effective, so it was never implemented on the OTC Market.
- Reverse stock split ratio of up to 1-for-20 was approved by stockholders in July 2021 and board in December 2021.

## SEC filing metadata
- accession: 0001477932-22-005479
- form_type: 8-K
- ticker: GTHP
- cik: 0000924515
- company_name: GUIDED THERAPEUTICS INC
- filed_at: 2022-07-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/924515/000147793222005479/0001477932-22-005479-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/924515/000147793222005479/gthp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-22-005479
- JSON: https://secwatch.observer/filing/0001477932-22-005479.json
- Plain text: https://secwatch.observer/filing/0001477932-22-005479.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.